In some tumors, like glioblastomas, alterations of the gene encoding TERT, such as TERT promoter (TERTp) mutations or methylation at the TERTp, can cause the overexpression of TERT and confer a proliferative advantage to neoplastic cells [98] (Figure 3). This evidence concerns the gene TERT and glioblastoma.